VBIV Vaccines Announces Data and Safety Monitoring Board Reviewed Complete Safety Data From Patient Cohort In Phase 1/2a Study Of VBI-1901 in Recurrent Glioblastoma (GBM) Patients; Committee Unanimously Recommended Continuation Of Study